Jeff Yass’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,700
| Closed | -$15K | – | 12600 |
|
|
2022
Q3 | $15K | Sell |
10,700
-5,000
| -32% | -$9.77K | ﹤0.01% | 12695 |
|
|
2022
Q2 | $34K | Buy |
+15,700
| New | +$36K | ﹤0.01% | 12161 |
|
|
2022
Q1 | – | Sell |
-17,600
| Closed | -$74K | – | 13116 |
|
|
2021
Q4 | $74K | Sell |
17,600
-36,400
| -67% | -$204K | ﹤0.01% | 12330 |
|
|
2021
Q3 | $438K | Sell |
54,000
-56,900
| -51% | -$462K | ﹤0.01% | 9724 |
|
|
2021
Q2 | $837K | Sell |
110,900
-42,900
| -28% | -$361K | ﹤0.01% | 8251 |
|
|
2021
Q1 | $1.33M | Buy |
153,800
+104,400
| +211% | +$995K | ﹤0.01% | 6961 |
|
|
2020
Q4 | $394K | Buy |
49,400
+4,600
| +10% | +$38.5K | ﹤0.01% | 8758 |
|
|
2020
Q3 | $357K | Sell |
44,800
-800
| -2% | -$7.22K | ﹤0.01% | 8358 |
|
|
2020
Q2 | $451K | Sell |
45,600
-23,900
| -34% | -$219K | ﹤0.01% | 7572 |
|
|
2020
Q1 | $537K | Buy |
69,500
+55,300
| +389% | +$279K | ﹤0.01% | 6781 |
|
|
2019
Q4 | $55K | Buy |
+14,200
| New | +$61.9K | ﹤0.01% | 9321 |
|
|
2019
Q2 | – | Sell |
-15,200
| Closed | -$115K | – | 10286 |
|
|
2019
Q1 | $115K | Buy |
+15,200
| New | +$118K | ﹤0.01% | 8187 |
|
|
2018
Q3 | – | Sell |
-12,200
| Closed | -$139K | – | 9342 |
|
|
2018
Q2 | $139K | Sell |
12,200
-1,700
| -12% | -$16.1K | ﹤0.01% | 8891 |
|
|
2018
Q1 | $98K | Sell |
13,900
-14,600
| -51% | -$110K | ﹤0.01% | 8712 |
|
|
2017
Q4 | $185K | Sell |
28,500
-27,200
| -49% | -$173K | ﹤0.01% | 8337 |
|
|
2017
Q3 | $345K | Sell |
55,700
-14,400
| -21% | -$73.4K | ﹤0.01% | 7155 |
|
|
2017
Q2 | $301K | Buy |
70,100
+31,200
| +80% | +$137K | ﹤0.01% | 7590 |
|
|
2017
Q1 | $175K | Buy |
38,900
+28,800
| +285% | +$161K | ﹤0.01% | 8108 |
|
|
2016
Q4 | $55K | Sell |
10,100
-4,000
| -28% | -$21.9K | ﹤0.01% | 9263 |
|
|
2016
Q3 | $90K | Sell |
14,100
-10,200
| -42% | -$53K | ﹤0.01% | 7975 |
|
|
2016
Q2 | $111K | Buy |
24,300
+5,100
| +27% | +$22.2K | ﹤0.01% | 7970 |
|
|
2016
Q1 | $75K | Sell |
19,200
-9,700
| -34% | -$42.1K | ﹤0.01% | 8540 |
|
|
2015
Q4 | $161K | Sell |
28,900
-23,800
| -45% | -$162K | ﹤0.01% | 8598 |
|
|
2015
Q3 | $333K | Sell |
52,700
-20,800
| -28% | -$139K | ﹤0.01% | 7861 |
|
|
2015
Q2 | $454K | Buy |
+73,500
| New | +$500K | ﹤0.01% | 7809 |
|
Other funds holding CTSO
AC
CM
SC
SIG
Jeff Yass's CTSO Position: Q2 2026 in Review
Jeff Yass sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 29,945 shares — an estimated $17K sold.
Jeff Yass first reported a position in CTSO in Q1 2015 and held it in 36 quarters. The position peaked at $1.11M in Q3 2017. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.
- Jeff Yass reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
- Jeff Yass sold 29,945 Cytosorbents Corp shares in Q2 2026, an estimated $17K.
- Jeff Yass first reported a position in Cytosorbents Corp in Q1 2015 and held it in 36 quarters.
- Jeff Yass's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
- 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.